Research & Development
- Therapeutic Areas of Interest
- Research Pipeline
- Development Process
- Clinical Trials
- Research Organization Profiles
- Research and Development Disclaimer
Our Vision
Our core concept remains unique in clinical drug development. Despite numerous other pharmaceutical and biotech companies worldwide, Quigley Pharma is one of the few companies working to create prescription and non-prescription drugs from natural sources to address current and emerging health crises.
Therapeutic Areas
Quigley Pharma Research and Development is focused on the following Therapeutic Areas of Interest: Diabetes Complications, Arthritis, Viral Infections,
+ More
Research Pipeline
The Quigley Pharma Pipeline has several compounds in various stages of development. Our lead compound, QR-333 is …
+ More
Development Process
The Development process starts with research into ethno botanical and traditional medicinal resources...
+ More
Researcher Profiles
Quigley Pharma is committed to working together with Key Opinion Leaders as well as world class research facilities in University and Private settings in the
+ More
Latest News
12/03/09
QUIGLEY CEO, TED KARKUS, ANNOUNCES PHASE ONE OF 2010 STRATEGIC PLAN
07/22/09
QUIGLEY CORPORATION ANNOUNCES FINAL RESULTS OF QUIGLEY PHARMA'S PHASE IIB STUDY
07/17/09
TED KARKUS NAMED CEO OF THE QUIGLEY CORPORATION
Email Updates
- Sign up for timely updates from Quigley Pharma, Inc.

![[Qlogo.gif] [Qlogo.gif]](http://www.quigleypharma.com/uploads/images/Qlogo.gif)